RhumbLine Advisers’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-57,190	Closed	-$518K	–	3002
2013 Q4	$518K	Sell	57,190 -200	-0.3%	-$1.81K	﹤0.01%	2235
2013 Q3	$362K	Sell	57,390 -578	-1%	-$3.65K	﹤0.01%	2411
2013 Q2	$395K	Buy	+57,968	New	+$395K	﹤0.01%	2435